期刊文献+

Adiponectin as a protective factor in hepatic steatosis 被引量:12

Adiponectin as a protective factor in hepatic steatosis
暂未订购
导出
摘要 AIM: Obesity and insulin resistance (IR) are closely related to hepatic steatosis (HS), and adiponectin is a hepatic insulin sensitizer that has important effects in liver function. This study aims at investigating the relationship between serum adiponectin concentration and the presence of HS. METHODS: We carried out a cross-sectional study in a check-up unit of a University Hospital in Mexico City. We enrolled 196 subjects, comprising 98 subjects with HS (27 women, 71 men) and 98 controls (37 women and 61 men). Anthropometric, metabolic and biochemical variables were measured in the two groups. Serum adiponectin and leptin concentrations were determined, their association with grade of HS tested, and concentrations, according to quartiles, compared between cases and controls. X2 analysis for linear trends was used to test for a dose-response relationship and logistic regression analysis was conducted to test for a protective effect of adiponectin. RESULTS: The HS subjects were older and more obese than controls, with a central obesity pattern. In the fourth quartile of adiponectin concentrations, HS was less common and severe. In a multivariate model of the fourth quartile of the adiponectin concentrations, we observed a protective effect (OR = 0.17, 95%CI: 0.04-0.67, P= 0.01). In subjects with more severe HS, we observed higher leptin concentrations, and caloric intakes, total fat and iron consumption were higher than in controls. CONCLUSION: The results of the present study suggest that a high serum concentration of adiponectin is associated with a protective effect against HS. AIM: Obesityand insulin resistance (IR) are closely related to hepatic steatosis (HS), and adiponectin is a hepatic insulin sensitizer that has important effects in liver function.This study aims at investigating the relationship between serum adiponectin concentration and the presence of HS.METHODS: We carried out a cross-sectional study in a check-up unit of a University Hospital in Mexico City. We enrolled 196 subjects, comprising 98 subjects with HS (27 women, 71 men) and 98 controls (37 women and 61men). Anthropometric, metabolic and biochemical variables were measured in the two groups. Serum adiponectin and leptin concentrations were determined,their association with grade of HS tested, and concentrations,according to quartiles, compared between cases and controls. χ2 analysis for linear trends was used to test for a dose-response relationship and logistic regression analysis was conducted to test for a protective effect of adiponectin.RESULTS: The HS subjects were older and more obese than controls, with a central obesity pattern. In the fourth quartile of adiponectin concentrations, HS was less common and severe. In a multivariate model of the fourth quartile of the adiponectin concentrations, we observed a protective effect (OR = 0.17, 95%CI: 0.04-0.67, P= 0.01).In subjects with more severe HS, we observed higher leptin concentrations, and caloric intakes, total fat and iron consumption were higher than in controls.CONCLUSION: The results of the present study suggest that a high serum concentration of adiponectin is associated with a protective effect against HS.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2005年第12期1737-1741,共5页 世界胃肠病学杂志(英文版)
关键词 ADIPONECTIN Hepatic steatosis LEPTIN DIET 脂肪肝 保护机制 胰岛素抵抗 肥胖
  • 相关文献

参考文献30

  • 1[1]Wanless IR,Lentz JS.Fatty liver hepatitis (steatohepatitis)and obesity:an autopsy study with analysis of risk factors.Hepatology 1990; 12:1106-1110
  • 2[2]Sanyal AJ,Campbell-Sargent C,Mirshahi F,Rizzo WB,Contos MJ,Sterling RK,Luketic VA,Shiffman ML,Clore JN.Nonalcoholic steatohepatitis:association of insulin resistance and mitochondrial abnormalities.Gastroenterology 2001; 120:1183-1192
  • 3[3]Wang RT,Koretz RL,Yee HF Jr.Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review.Am J Med 2003; 115:554-559
  • 4[4]Musso G,Gambino R,De Michieli F,Cassader M,Rizzetto M,Durazzo M,Faga E,Silli B,Pagano G.Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis.Hepatology 2003; 37:909-916
  • 5[5]Garcia Monzon C.Non-alcoholic steatohepatitis.Gastroenterol Hepatol 2001; 24:395-402
  • 6[6]Hotamisligil GS,Arner P,Caro JF,Atkinson RL,Spiegelman BM.Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.J Clin Invest 1995; 95:2409-2415
  • 7[7]Goldstein BJ,Scalia R.Adiponectin:A novel adipokine linking adipocytes and vascular function.J Clin Endocrinol Metab 2004; 89:2563-2568
  • 8[8]Day CP,James OF.Hepatic steatosis:innocent bystander or guilty party? Hepatology 1998; 27:1463-1466
  • 9[9]Friedman JM.The function of leptin in nutrition,weight,and physiology.Nutr Rev 2002; 60(10 Pt 2):S1-14
  • 10[10]Saadeh S,Younossi ZM,Remer EM,Gramlich T,Ong JP,Hurley M,Mullen KD,Cooper JN,Sheridan MJ.The utility of radiological imaging in nonalcoholic fatty liver disease.Gastroenterology 2002; 123:745-750

同被引文献225

引证文献12

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部